Information papers

Biologics Icon
Information paper
Monoclonal antibody therapy for severe asthma

Four monoclonal antibody therapies (benralizumab, mepolizumab, dupilumab and omalizumab) are available in Australia for the treatment of severe asthma in patients whose asthma is uncontrolled despite optimised standard treatment.